Status:
UNKNOWN
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
30-75 years
Brief Summary
Non-alcoholic fatty liver disease (NAFLD) is now recognised as the hepatic complication of the metabolic syndrome of insulin resistance. In some patients, the disease can progress into steatohepatitis...
Eligibility Criteria
Inclusion
- metabolic syndrome with 3 out of 5 criteria (ATP III definition)
Exclusion
- alcohol intake \> 20g/day (women), \> 30g/day (men)
- chronic liver disease of other cause: viral hepatitis (HBV, HCV), Wilson's disease, haemochromatosis, alpha1 anti-trypsin deficiency, drug-induced, ...
- decompensated cirrhosis (Child-Pugh 3)
- body weight \> 120 Kg
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00399932
Start Date
March 1 2006
End Date
May 1 2010
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
StLuc University Hospital
Brussels, Belgium, 1200